AbbVie Inc. Executive Compensation

Named executive officer pay as disclosed in the company’s abbv-20260508xdef14a.htm proxy statement (SEC Form DEF 14A). Figures are total annual compensation for the most recent fiscal year reported.

$32,530,984

Robert A. Michael, Chief Executive Officer — total compensation

$1,700,000

base salary

Healthcare

industry

Executive	Title	Base salary	Total compensation
Robert A. Michael	Chairman of the Board and Chief Executive Officer	$1,700,000	$32,530,984
Jeffrey R. Stewart	Executive Vice President, Chief Commercial Officer	$1,315,726	$15,435,304
Scott T. Reents	Executive Vice President, Chief Financial Officer	$1,124,116	$12,353,002
Azita Saleki-Gerhardt	Executive Vice President, Chief Operations Officer	$1,052,581	$10,791,976
Roopal B. Thakkar	Executive Vice President, Research & Development and Chief Scientific Officer	$1,146,154	$9,912,843

Source: AbbVie Inc. Definitive Proxy Statement (DEF 14A), filed abbv-20260508xdef14a.htm with the U.S. Securities and Exchange Commission. View the filing on SEC.gov. Total compensation reflects the Summary Compensation Table and includes salary, bonus, stock and option awards, non-equity incentive pay, and all other compensation as defined by SEC rules.